Big pharma megamerger
---------------------------------------------------------------------
A $160 billion deal to merge Pfizer and Dublin-based Allergan will create a drug powerhouse with combined revenue of $62.7bn. Pfizer will move its tax base to Ireland to slash its U.S. tax bill by $21bn
---------------------------------------------------------------------
Top 10 pharmaceutical  companies by 2014 revenue
Johnson & Johnson $74.33bn
Novartis $57.99bn
Roche $49.86bn
Pfizer $49.61bn Allergan $13.10bn
Sanofi $43.07bn
Merck & Co. $42.24bn
GlaxoSmithKline $37.96bn
AstraZeneca $26.10bn
Bayer HealthCare $25.47bn
Gilead Sciences $24.474bn
0 10 20 30 40 50 60 70 80
---------------------------------------------------------------------
Top-selling medications
Lyrica – $5.16 billion (epilepsy, neuropathy)
Prevnar – $4.46 billion (prevention of pneumococcal pneumonia)
Viagra – $1.68 billion (erectile dysfunction)
Botox – $2 billion* (anti-wrinkle treatment)
Restasis – $940 million* (dry-eye treatment)

---------------------------------------------------------------------
Sources: Fierce Pharma, Contract Pharma, Statista
*2013 figures
words 122